Anders Larsson Selected Research

Shock

3/2019	The effect of hemorrhagic shock and intraosseous adrenaline injection on the delivery of a subsequently administered drug - an experimental study.
1/2015	Troponin I can be Determined in Intraosseous Aspirates in a Porcine Shock Model.
9/2012	Counteraction of early circulatory derangement by administration of low dose steroid treatment at the onset of established endotoxemic shock is not directly mediated by TNF-α and IL-6.
11/2009	Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.
3/2009	Inflammatory and circulatory effects of the reduction of endotoxin concentration in established porcine endotoxemic shock--a model of endotoxin elimination.
3/2008	F2-isoprostane, inflammation, cardiac function and oxygenation in the endotoxaemic pig.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Larsson Research Topics

Disease

66	Inflammation (Inflammations) 01/2024 - 01/2002
36	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 07/2005
26	Critical Illness (Critically Ill) 01/2023 - 04/2004
25	Sepsis (Septicemia) 09/2023 - 01/2002
22	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 02/2003
21	Neoplasms (Cancer) 05/2024 - 07/2003
20	Chronic Renal Insufficiency 01/2022 - 10/2009
18	Pre-Eclampsia (Preeclampsia) 01/2023 - 01/2003
15	Heart Failure 01/2023 - 07/2007
15	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 10/2009
15	Infections 06/2022 - 01/2002
14	COVID-19 05/2024 - 01/2021
13	Lung Injury 01/2021 - 07/2004
12	Coronary Disease (Coronary Heart Disease) 10/2021 - 12/2014
11	Septic Shock (Toxic Shock Syndrome) 04/2022 - 02/2004
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2024 - 11/2005
10	Hemorrhage 02/2023 - 11/2016
10	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 01/2006
9	Rheumatoid Arthritis 12/2023 - 01/2002
9	Type 2 Diabetes Mellitus (MODY) 01/2023 - 04/2004
9	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2010
9	Hypertension (High Blood Pressure) 10/2018 - 07/2005
9	Insulin Resistance 02/2015 - 07/2007
8	Atherosclerosis 01/2023 - 09/2008
8	Albuminuria 01/2021 - 09/2012
8	Obesity 12/2020 - 04/2004
7	Endotoxemia 01/2023 - 11/2005
7	Pneumonia (Pneumonitis) 11/2021 - 01/2009
7	Necrosis 04/2021 - 02/2004
7	Myocardial Ischemia (Ischemic Heart Diseases) 04/2021 - 12/2006
7	Myocardial Infarction 12/2018 - 10/2004
6	Kidney Diseases (Kidney Disease) 04/2024 - 06/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 10/2009
6	Virus Diseases (Viral Diseases) 01/2020 - 01/2002
6	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2003
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2019 - 08/2014
6	Shock 03/2019 - 03/2008
6	Acute Lung Injury 01/2016 - 02/2003
5	Overweight 04/2024 - 01/2014
5	Edema (Dropsy) 05/2022 - 07/2009
5	Hypoxia (Hypoxemia) 11/2021 - 10/2003
5	Stroke (Strokes) 10/2021 - 02/2008
5	Pulmonary Atelectasis 01/2020 - 11/2011

Drug/Important Bio-Agent (IBA)

84	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2003
37	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2003
33	Cystatin CIBA 01/2023 - 10/2004
27	C-Reactive ProteinIBA 11/2022 - 01/2002
25	CytokinesIBA 01/2023 - 04/2004
24	CreatinineIBA 01/2022 - 02/2008
23	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2002
21	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 07/2007
18	EndostatinsIBA 05/2024 - 10/2009
18	AntibodiesIBA 04/2023 - 01/2002
16	EndotoxinsIBA 11/2022 - 02/2004
15	AlbuminsIBA 04/2024 - 01/2004
14	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023 - 08/2014
13	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 06/2003
12	LipidsIBA 02/2024 - 01/2008
12	Oxygen (Dioxygen)IBA 10/2023 - 11/2002
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 12/2002
10	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 05/2013
9	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 09/2003
9	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022 - 11/2014
9	Insulin (Novolin)FDA Link 10/2014 - 04/2004
8	PTX3 proteinIBA 01/2023 - 10/2011
8	Antihypertensive Agents (Antihypertensives)IBA 01/2017 - 05/2008
7	Triglycerides (Triacylglycerol)IBA 02/2024 - 12/2006
7	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020 - 01/2017
7	cathepsin SIBA 01/2019 - 09/2011
7	Peptides (Polypeptides)IBA 01/2018 - 01/2004
7	ProstaglandinsIBA 10/2016 - 04/2004
6	Fibrinogen (Factor I)FDA Link 02/2024 - 01/2002
6	oxidized low density lipoproteinIBA 02/2024 - 12/2006
6	Lipocalin-2IBA 01/2024 - 04/2013
6	Indicators and Reagents (Reagents)IBA 01/2023 - 04/2004
6	Fibroblast Growth Factor-23IBA 01/2023 - 10/2009
6	LeptinIBA 12/2021 - 10/2009
6	EnzymesIBA 10/2021 - 08/2006
6	SeleniumIBA 10/2021 - 07/2005
6	Tuberculin (PPD)IBA 01/2020 - 10/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 04/2004
6	HDL CholesterolIBA 10/2014 - 05/2008
6	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2012 - 04/2004
5	Hemoglobins (Hemoglobin)IBA 02/2023 - 11/2002
5	Troponin IIBA 10/2022 - 05/2008
5	ProcalcitoninIBA 01/2022 - 11/2014
5	IgYIBA 01/2021 - 01/2002
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 05/2008
5	SolutionsIBA 01/2020 - 01/2008
5	Cathepsin BIBA 01/2020 - 01/2010
5	Type II Tumor Necrosis Factor ReceptorsIBA 01/2020 - 02/2015
5	CathepsinsIBA 01/2019 - 05/2011
5	AutoantibodiesIBA 10/2016 - 09/2004

Therapy/Procedure

26	Artificial Respiration (Mechanical Ventilation) 10/2022 - 01/2008
19	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 05/2022 - 02/2003
16	Critical Care (Surgical Intensive Care) 01/2023 - 01/2003
12	Therapeutics 01/2023 - 01/2002
7	Mechanical Ventilators (Ventilator) 01/2019 - 02/2003
6	Resuscitation 09/2023 - 11/2016
5	Catheters 01/2023 - 01/2010